معرفی
Professor Sabine Bahn is a practising psychiatrist, Chair in Neurotechnology, and Director of the Cambridge Centre for Neuropsychiatric Research at the University of Cambridge. She is also a Fellow of Lucy Cavendish College.
- Royal College of Psychiatrists
- British Medical Association
- American Neuroscience Association
- British Neuroscience Association
- British Association of Psychopharmacology
- World Federation of Societies of Biological Psychiatry
- Royal Society of Biology
Research Interests:
Sabine Bahn's work focuses on the molecular basis of neuropsychiatric disorders such as schizophrenia and mood disorders. She develops novel diagnostics and therapeutics, integrating neurotechnology and proteomics for biomarker discovery. Her research has led to the co-founding of two spin-out companies: Psynova Neurotech Ltd. (2005), which launched the first blood test for schizophrenia diagnosis, and PsyOmics Ltd. (2015), combining digital tools and blood-based biomarkers for mental health disorders like bipolar disorder and depression.
Scientific Contributions:
She has published over 180 high-impact articles, emphasizing proteomics and gene expression in psychiatric disorders. Her recent work includes CSF metabolic profiling, label-free LC-MSMS, and peptide correlation methods for biomarker validation.
Professional Affiliations:
She is actively involved in professional bodies such as the Royal College of Psychiatrists, British Neuroscience Association, and the Royal Society of Biology.
